Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

PsyBio Therapeutics Corp.

PSYB.V

HealthcareTSXVUS

CA$0.0075

-CA$0.0025 (-25.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

PSYB.V

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.01H 0.01L 0.01C 0.01Date Dec 22

PSYB.V

SMA 20 SMA 50 Vol 0EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Based in Coconut Creek, Florida, PsyBio Therapeutics Corp. operates as a biotechnology enterprise dedicated to the development, evaluation, and market launch of regulated pharmaceuticals rooted in psychedelic compounds. Its primary objective is to address various mental health issues and other ailments across the United States.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$956,543

Volume?211.00K

Avg Volume?6.80K

52w RangeCA$0.005 - CA$0.135

Beta?0.66

Price Performance

0.0%

CA$0.01 to CA$0.01

YTD

0.0%